{"name":"Siolta Therapeutics, Inc.","slug":"siolta-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxQblQ2eEttMko4Zk1MM0JDdjNXTURkeXRzLTdfLUVxVy1BQmZqZlNkbXd2cVViSDhiX2dybXE0UldoSHdEbjNTa2pwNF9xeWdFMWlSbzlZUEd6RGJ1SHM2OVVWUEpOeG1nbG9vdFlmalp1YzZNd29uT2R6eTZnZkJSbkJ3bmc0Zi1SdEE5OVA5TGlCc2VmSjM4bHV1enJFUFpFY2RsdmJ0dkJxVFJELXcyMDN1bUNaOU1KSHp2cjJKUEwySWxLYWZSWnM0WWxMZDVzSTdOOU15X3BTSUVNVFpEc2FYU1VfQVQ3RjhUcVpPUkprLU1haGkzN291M3JKMTNKNXloU1lZemtFaTh2R1J0VlNTZ0J0U25EQU91QTVsUGc?oc=5","date":"2026-04-07","type":"trial","source":"Business Upturn","summary":"Severe Asthma Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight - Business Upturn","headline":"Severe Asthma Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOaU5fWi1lNUE5QUpxdDBfdmNYUnhfa0lucXJ5d3F4UnRvM3ljT2pzdVVRNHY3TUhLNDBOQ0hHdk5xOFN2Y0pZaTlCWGRVZ2R1VzZ1YWxldkhrdUJRdTBJZ0tRbDlSRXA2ak15ektmemhvNFMycG16eXVNYWdROXRnZTlVQnRJNEthaDRXRTdVNFk5ZjRa?oc=5","date":"2026-04-02","type":"pipeline","source":"openPR.com","summary":"Allergic Rhinitis Market: Strong Pharma Growth Forecast Through 2034 - DelveInsight - openPR.com","headline":"Allergic Rhinitis Market: Strong Pharma Growth Forecast Through 2034 - DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxPR1NGbUF5LWVFdTdxNlBRbm54Q2tjTDhCV3JnVmtheVFCRFZxWkZXTGxfb3ZibldxV3pSOUZNMFNCTENmUGkzdlJCV0ctczk1R1dHaVgydWgyUkVWQUtmdl9QVEhUdzJaR1BsLTd4STlHUnJsUXhlWHJaSjdfeVh5VzcwTWVnci1TQXhvYWdQYkNqMTBlVy1jU19yTTR0dHlrVDhMTUFoR0tHRmhKOGhLaHRTczJuUk80aUpwWExFMFdGTVF5TzZPWXE5dkpBUVZCcHdTQXVpMU9obDlyUEtqc3RpSWJLQnpOalNwM0RCaHJ5bGRNZTBTa2JTUDZWMXllVFpLV3UtUWV3ak1YNlpVOGUwc0d5MFUzSV9F?oc=5","date":"2026-03-04","type":"pipeline","source":"PR Newswire UK","summary":"H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) | DelveInsight - PR Newswire UK","headline":"H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQOU93a2dWRnVjMW9QaW9BSDRuQVhZTkZfOXZfVDZrZTJpaTJySlNHaTFLV2VpeTc2dkVsT2c4RUtSMzB4cUVjdWdMNXR5bmtHWUpOM0FDTktNRlhCTUdJSXhlc1RwbGJaYjZ2eXowUzBlTE43eEZjX3l5bVU1NUtJVktQY0lNRGVxSUpyeFg1TWhKa0QyNXhndmlqV1MzMUNTUWY4UkVBdkRGWVNiSHFpY3B0NktpV0NVdnlwUEhfYTBXa1Nhc3lET0lR?oc=5","date":"2025-11-17","type":"trial","source":"prnewswire.com","summary":"Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study - prnewswire.com","headline":"Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNVkFxbjN4UVBrOEp2MkZpQ0kydjFVZWlmcGptTjhDWjhrakVMVUY0WGZJVzVBa1padWo2MlQxZ3BoRm5LbFpiUVh0X21NcXBsSEFLWHhTd3RodjJaS1hjR2hYbGNwZnF6WVlsZm8tLVNPWTJzaEFBamFScDkyZ3V5ODU1OXBhS0ZkN0RnYkhNYnhYNHItZERQWng5UjExcXh6eVhUTzFhMVVQNjBqUVFOYXYzMThpdW0wSEUwdWRR?oc=5","date":"2025-01-29","type":"pipeline","source":"businesswire.com","summary":"Siolta Therapeutics and Cowellnex Enter Joint Research Agreement - businesswire.com","headline":"Siolta Therapeutics and Cowellnex Enter Joint Research Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxQUUNHOVByblZQNF96UFZuWE1Td19VSVpRa2dQU1pqdHN6a3dnTjZTUUdDTnViZ0Vub1dMNUc5djFWVlZlb0ZIOGxXWWMtU3NaVFUyVWU2cGRZRm01NEwzSzVYdE45OF91MF9BeU9iVHpaTEN5NmYyM2FvX1h6Z3hYSFNzY3pzbDlaYm9DbDAxa0FMWXN3RHE1V29OU1JGMVU4eWpRQTJHZ25WWGkzR1dmNjJFY0hEOVI4ZnRyMUo1ekg3b0VFaHpwbUp2M3dnbnZYX29mcEdKaEFUMy1ab2NsYkd4OVJaUHV4dTdLeUFzZzlKM3lzNEg1eXh1Q3UySmdpM09GOXNQamRjZF9sb2N3TERjSmhoajJLRTV3?oc=5","date":"2024-09-17","type":"deal","source":"businesswire.com","summary":"Nexilico and Siolta Therapeutics Enter Collaboration Agreement to Develop a Novel Microbiome Therapeutic for Necrotizing Enterocolitis - businesswire.com","headline":"Nexilico and Siolta Therapeutics Enter Collaboration Agreement to Develop a Novel Microbiome Therapeutic for Necrotizing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPZ0J4eTFsRXU1QnNaNkFmb1RFTlBvdmhsWFRmRi03eGpWdFdXd2g1bDRCcFh3aUlsSlR3LXBjdVlkbzAtTWgxS0VQMGFtZ3NweXA4aWhzLXpzOU1Yb2VpRUZGTGljbWw3SG4tWkJIOUlBZlFCUW1WWE90VzFWVVEzdzBXM1d1M2ZwZmswMVRyS3VCSmw4YkJTZXdzMkhwRWJUeHFMR0Z0b2ZCdDJaQmF0MGRsTHU2LVFsTVMtT2c4MVF1SHd4THhSV0lDS3pIUmRMRXkyc0FOanBDZ24x?oc=5","date":"2024-03-14","type":"pipeline","source":"businesswire.com","summary":"Siolta Therapeutics Raises $12 Million in Series C Financing for Clinical Development - businesswire.com","headline":"Siolta Therapeutics Raises $12 Million in Series C Financing for Clinical Development","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}